Literature DB >> 15944566

Localization by unilateral BAHA users.

Jack J Wazen1, Soha N Ghossaini, Jaclyn B Spitzer, Mary Kuller.   

Abstract

OBJECTIVES: Patients with unilateral hearing loss report difficulty hearing conversation on their impaired side, localizing sound, and understanding of speech in background noise. The bone-anchored cochlear stimulator (BAHA) (Entific, Gothenburg, Sweden) has been shown to improve performance in persons with unilateral severe-profound sensorineural loss (USNHL). The purpose of this study is to evaluate the effectiveness of BAHA in sound localization for USNHL listeners. STUDY
DESIGN: Prospective study of 12 USNHL subjects, 9 of whom received implants on the poorer hearing side. A control group of 10 normal hearing subjects were assessed for comparison. Localization with and without BAHA was assessed using an array of 8 speakers at head level separated by 45 degrees. Error analysis matrix was generated to evaluate the confusions, accuracy in response, and laterality judgment.
RESULTS: The average accuracy of speaker localization was 16% in the unaided condition, with no improvement with BAHA use. Laterality judgment was poorer than 43% in both aided and nonaided conditions.
CONCLUSIONS: Patients with UNSNHL had poor sound localization and laterality judgment abilities that did not improve with BAHA use.

Entities:  

Mesh:

Year:  2005        PMID: 15944566     DOI: 10.1016/j.otohns.2005.03.014

Source DB:  PubMed          Journal:  Otolaryngol Head Neck Surg        ISSN: 0194-5998            Impact factor:   3.497


  23 in total

1.  BAHA: Bone-Anchored Hearing Aid.

Authors:  Abdulrahman Hagr
Journal:  Int J Health Sci (Qassim)       Date:  2007-07

2.  Nonsurgical Management of Single-Sided Deafness: Contralateral Routing of Signal.

Authors:  Hillary Snapp
Journal:  J Neurol Surg B Skull Base       Date:  2019-01-17

3.  Quantification of speech-in-noise and sound localisation abilities in children with unilateral hearing loss and comparison to normal hearing peers.

Authors:  Ruth M Reeder; Jamie Cadieux; Jill B Firszt
Journal:  Audiol Neurootol       Date:  2015-05-19       Impact factor: 1.854

4.  Informational masking and spatial hearing in listeners with and without unilateral hearing loss.

Authors:  Ann M Rothpletz; Frederic L Wightman; Doris J Kistler
Journal:  J Speech Lang Hear Res       Date:  2012-01-03       Impact factor: 2.297

5.  Effectiveness in Rehabilitation of Current Wireless CROS Technology in Experienced Bone-Anchored Implant Users.

Authors:  Hillary A Snapp; Michael E Hoffer; Xuezhong Liu; Suhrud M Rajguru
Journal:  Otol Neurotol       Date:  2017-12       Impact factor: 2.311

6.  Comparison of Speech-in-Noise and Localization Benefits in Unilateral Hearing Loss Subjects Using Contralateral Routing of Signal Hearing Aids or Bone-Anchored Implants.

Authors:  Hillary A Snapp; Fred D Holt; Xuezhong Liu; Suhrud M Rajguru
Journal:  Otol Neurotol       Date:  2017-01       Impact factor: 2.311

7.  Localization training results in individuals with unilateral severe to profound hearing loss.

Authors:  Jill B Firszt; Ruth M Reeder; Noël Y Dwyer; Harold Burton; Laura K Holden
Journal:  Hear Res       Date:  2014-11-29       Impact factor: 3.208

8.  Improved horizontal directional hearing in bone conduction device users with acquired unilateral conductive hearing loss.

Authors:  Martijn J H Agterberg; Ad F M Snik; Myrthe K S Hol; Thamar E M van Esch; Cor W R J Cremers; Marc M Van Wanrooij; A John Van Opstal
Journal:  J Assoc Res Otolaryngol       Date:  2010-09-14

Review 9.  Amplification considerations for children with minimal or mild bilateral hearing loss and unilateral hearing loss.

Authors:  Sarah McKay; Judith S Gravel; Anne Marie Tharpe
Journal:  Trends Amplif       Date:  2008-03

10.  Pilot study on the effectiveness of the conventional CROS, the transcranial CROS and the BAHA transcranial CROS in adults with unilateral inner ear deafness.

Authors:  Myrthe K S Hol; Sylvia J W Kunst; Ad F M Snik; Cor W R J Cremers
Journal:  Eur Arch Otorhinolaryngol       Date:  2009-11-11       Impact factor: 2.503

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.